Clinical Trials Logo

Filter by:
  • Withdrawn  
  • « Prev · Page [17]
NCT ID: NCT00168051 Withdrawn - Hemophilia A Clinical Trials

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

Start date: April 2005
Phase: Phase 4
Study type: Interventional

The purpose of the study is to compare the pharmacokinetic parameters of ReFacto and Advate, using the chromogenetic substrate assay to measure plasma Factor VIII activity in plasma.

NCT ID: NCT00151385 Withdrawn - Hemophilia A Clinical Trials

Study Evaluating Inhibitor Specificity in Hemophilia A

Start date: November 2005
Phase: Phase 4
Study type: Interventional

This investigation will utilize a systematic determination of anti-FVIII antibody specificity in PTPs (> 50 ED) with hemophilia A who have developed inhibitors in response to treatment with any FVIII product(s). A group of patients with hemophilia A, who have no evidence of current or prior FVIII inhibitor will be included for comparison. The objective of this study is to describe the patterns of antibodies and associated epitopes in the study population.